A detailed history of Highlander Capital Management, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Highlander Capital Management, LLC holds 4,700 shares of ZTS stock, worth $831,712. This represents 0.32% of its overall portfolio holdings.

Number of Shares
4,700
Previous 4,775 1.57%
Holding current value
$831,712
Previous $942,000 15.61%
% of portfolio
0.32%
Previous 0.41%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 20, 2024

SELL
$165.67 - $199.94 $12,425 - $14,995
-75 Reduced 1.57%
4,700 $795,000
Q2 2023

Aug 14, 2023

SELL
$160.94 - $186.23 $266,355 - $308,210
-1,655 Reduced 25.74%
4,775 $822,000
Q2 2022

Aug 15, 2022

BUY
$155.97 - $200.09 $202,761 - $260,117
1,300 Added 25.34%
6,430 $1.11 Million
Q4 2021

Feb 14, 2022

SELL
$193.69 - $247.03 $145,267 - $185,272
-750 Reduced 12.76%
5,130 $1.25 Million
Q4 2020

Feb 12, 2021

SELL
$157.07 - $174.35 $31,414 - $34,870
-200 Reduced 3.29%
5,880 $973,000
Q3 2020

Nov 17, 2020

BUY
$137.1 - $165.37 $27,420 - $33,074
200 Added 3.4%
6,080 $1.01 Million
Q2 2020

Aug 17, 2020

SELL
$111.92 - $142.53 $33,576 - $42,759
-300 Reduced 4.85%
5,880 $806,000
Q4 2019

Feb 13, 2020

BUY
$116.25 - $133.25 $34,875 - $39,975
300 Added 5.1%
6,180 $818,000
Q2 2019

Aug 14, 2019

SELL
$97.98 - $114.28 $68,586 - $79,996
-700 Reduced 10.64%
5,880 $667,000
Q1 2019

May 15, 2019

SELL
$81.56 - $100.67 $142,730 - $176,172
-1,750 Reduced 21.01%
6,580 $662,000
Q4 2018

Feb 14, 2019

SELL
$79.28 - $95.27 $106,631 - $128,138
-1,345 Reduced 13.9%
8,330 $712,000
Q1 2018

May 16, 2018

SELL
$71.51 - $84.69 $143,020 - $169,380
-2,000 Reduced 17.13%
9,675 $785,000
Q3 2017

Nov 15, 2017

BUY
$59.73 - $65.4 $697,347 - $763,545
11,675
11,675 $744,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Highlander Capital Management, LLC Portfolio

Follow Highlander Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highlander Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highlander Capital Management, LLC with notifications on news.